Operator of a bioscience and genetic engineering company committed to building radical new technologies to advance the f
Biotechnology📍 Austin, TXFounded 2021
Current Valuation
$10B
as of 2025-Q3
DECACORN
Colossal Biosciences applies genetic engineering, computational biology and AI to de-extinction and species preservation — reconstructing lost species such as the woolly mammoth, thylacine and dodo while applying the same tooling to conservation genetics for endangered animals and to human healthcare. Founded in 2021 by Ben Lamm and Harvard geneticist George Church, it became Texas's first decacorn. It has spun out three companies (Form Bio, Breaking and Astromech) and has begun earning revenue from conservation-technology contracts, including work for the U.S. government and the UAE.
Company Profile
CEO
Ben Lamm
Founded
2021
HQ
Austin, TX
Employees
193
Total Raised
$557.6M
Growth
Reached a $10.32B valuation on ~$557M raised since 2021 — Texas's first decacorn — and reportedly entered talks in July 2026 to raise at $20B-$30B, which would be a two-to-threefold step-up 16 months after the last round; the company began generating revenue over the past year
Last Round
Series C — $320M (Sep 2025) · Lead: TWG Global
IPO Status
private
Fundraising Status
Series C · $320M · 11 mo ago
privateTotal raised $557.6M
Secondary Market
Implied price / share
$8.5
Last round price / share
$24.89
vs last round
-65.8%
Open interest
3
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$320M
Sep 2025
TWG Global
$10B
Founders & Key People
Ben LammGeorge Church
Investors
TWG Global · Breyer Capital · Bob Nelsen · Paul Tudor Jones · At One Ventures · Winklevoss Capital · In-Q-Tel · United Arab Emirates (sovereign investment)
Products
De-extinction programs (woolly mammoth, thylacine, dodo, dire wolf, bluebuck and others)
Conservation genetics and biobanking for endangered species
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q3. Refreshed quarterly.